搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
enta
/
财务摘要
Enanta Pharmaceuticals Inc
ENTA
添加自选
12.200
USD
-0.320
-2.56%
收盘 09-17 16:00(美东)
355.56M
总市值
亏损
市盈率 TTM
Enanta Pharmaceuticals Inc
12.200
-0.320
-2.56%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
ENTA 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Enanta Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
355.56M
股息TTM
0.00
市盈率 TTM
-4.71
每股收益TTM
-2.59
营业收入
65.32M
净利润
-81.89M
净资产收益率
-59.00%
总资产收益率
-19.44%
Enanta Pharmaceuticals Inc 财报日历
最新发布
8月 12, 2026
每股收益 / 预测值
-0.67
/-0.51
营业收入 / 预测值
14.36M
/16.80M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
财务指标
每股收益
21.50%
-0.67
57.49%
-0.45
60.43%
-0.42
35.68%
-0.87
20.17%
-0.85
27.96%
-1.06
33.75%
-1.05
-1.90%
-1.36
42.34%
-1.07
17.78%
-1.47
-13.77%
-1.58
--
-1.33
--
-1.86
--
-1.79
--
-1.39
--
--
--
--
--
--
--
--
--
--
营业收入
-21.60%
14.36M
14.96%
17.16M
9.76%
18.61M
3.55%
15.13M
1.91%
18.31M
-12.48%
14.93M
-5.80%
16.96M
-22.84%
14.61M
-4.88%
17.97M
-4.16%
17.05M
-23.67%
18.00M
-6.82%
18.93M
-3.01%
18.89M
-4.92%
17.80M
-14.70%
23.59M
-13.82%
20.32M
-9.92%
19.48M
-7.03%
18.72M
-12.90%
27.65M
-0.24%
23.57M
净利润
-6.83%
-19.50M
42.19%
-13.09M
46.44%
-11.94M
35.12%
-18.70M
19.43%
-18.25M
27.32%
-22.64M
33.28%
-22.29M
-2.55%
-28.82M
42.00%
-22.66M
17.26%
-31.16M
-15.25%
-33.41M
-6.68%
-28.11M
-23.23%
-39.06M
-12.10%
-37.66M
3.75%
-28.99M
-7.11%
-26.35M
-31.95%
-31.70M
-52.38%
-33.59M
-261.61%
-30.11M
16.16%
-24.60M
利润率
-36.25%
-135.81%
49.71%
-76.29%
51.21%
-64.13%
37.34%
-123.64%
20.94%
-99.68%
16.96%
-151.71%
29.17%
-131.43%
-32.91%
-197.32%
39.03%
-126.08%
13.67%
-182.70%
-50.99%
-185.56%
--
-148.46%
--
-206.78%
--
-211.62%
--
-122.90%
--
--
--
--
--
--
--
--
--
--
毛利率
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
--
100.00%
--
100.00%
--
100.00%
--
100.00%
--
--
--
--
--
--
--
--
--
--
资产负债率
9392.97%
42.57%
9789.32%
41.33%
10568.06%
41.31%
14127.10%
50.99%
25.69%
0.45%
21.47%
0.42%
16.60%
0.39%
16.43%
0.36%
24.16%
0.36%
-21.06%
0.34%
-18.90%
0.33%
--
0.31%
--
0.29%
--
0.44%
--
0.41%
--
--
--
--
--
--
--
--
--
--
利润表
营业收入
-21.60%
14.36M
14.96%
17.16M
9.76%
18.61M
3.55%
15.13M
1.91%
18.31M
-12.48%
14.93M
-5.80%
16.96M
-22.84%
14.61M
-4.88%
17.97M
-4.16%
17.05M
-23.67%
18.00M
-6.82%
18.93M
-3.01%
18.89M
-4.92%
17.80M
-14.70%
23.59M
-13.82%
20.32M
-9.92%
19.48M
-7.03%
18.72M
-12.90%
27.65M
-0.24%
23.57M
营业利润
8.77%
-17.24M
51.68%
-11.85M
52.20%
-11.25M
38.41%
-18.39M
21.88%
-18.89M
25.14%
-24.53M
32.51%
-23.54M
3.79%
-29.85M
34.12%
-24.18M
16.95%
-32.77M
-16.24%
-34.89M
-14.72%
-31.03M
-12.82%
-36.71M
-16.56%
-39.45M
1.30%
-30.01M
19.80%
-27.05M
3.86%
-32.54M
-13.96%
-33.85M
-147.25%
-30.41M
-70.48%
-33.73M
净利润
-6.83%
-19.50M
42.19%
-13.09M
46.44%
-11.94M
35.12%
-18.70M
19.43%
-18.25M
27.32%
-22.64M
33.28%
-22.29M
-2.55%
-28.82M
42.00%
-22.66M
17.26%
-31.16M
-15.25%
-33.41M
-6.68%
-28.11M
-23.23%
-39.06M
-12.10%
-37.66M
3.75%
-28.99M
-7.11%
-26.35M
-31.95%
-31.70M
-52.38%
-33.59M
-261.61%
-30.11M
16.16%
-24.60M
资产负债表
流动资产
-8.57%
203.62M
-26.54%
178.41M
-25.90%
198.68M
-31.85%
204.34M
-22.29%
222.71M
-30.81%
242.86M
-31.30%
268.14M
-29.08%
299.85M
-36.10%
286.58M
29.47%
351.03M
37.57%
390.30M
35.63%
422.79M
43.26%
448.46M
-20.69%
271.14M
-13.23%
283.70M
-2.29%
311.71M
-2.53%
313.04M
-20.16%
341.87M
-26.68%
326.96M
-26.97%
319.02M
流动负债总额
21.59%
54.17M
1.08%
46.44M
-8.81%
44.73M
-15.61%
48.55M
-26.04%
44.55M
-15.86%
45.95M
-21.40%
49.05M
-8.36%
57.53M
-11.66%
60.24M
69.77%
54.61M
171.32%
62.41M
110.50%
62.79M
196.02%
68.19M
4.65%
32.17M
-39.30%
23.00M
-17.54%
29.83M
-19.53%
23.04M
15.48%
30.74M
64.42%
37.89M
49.74%
36.17M
总资产
-1.38%
296.87M
-2.57%
314.70M
-5.49%
329.50M
-25.47%
280.73M
-24.52%
301.03M
-21.90%
322.99M
-18.64%
348.64M
-18.52%
376.65M
-19.46%
398.82M
26.69%
413.56M
23.30%
428.50M
23.14%
462.27M
28.54%
495.17M
-19.76%
326.44M
-21.12%
347.53M
-14.44%
375.41M
-14.48%
385.21M
-13.03%
406.82M
-8.40%
440.59M
-9.74%
438.79M
总负债
-11.70%
195.80M
-13.66%
198.12M
-14.32%
202.91M
-12.84%
216.01M
-11.97%
221.75M
-7.27%
229.46M
0.09%
236.83M
0.94%
247.84M
-2.11%
251.91M
333.58%
247.44M
406.70%
236.62M
354.06%
245.54M
445.34%
257.35M
18.32%
57.07M
-16.92%
46.70M
37.38%
54.08M
44.82%
47.19M
51.99%
48.23M
93.71%
56.21M
28.84%
39.36M
总权益
27.48%
101.07M
24.64%
116.59M
13.21%
126.59M
-49.76%
64.72M
-46.76%
79.28M
-43.69%
93.54M
-41.73%
111.82M
-40.57%
128.81M
-37.38%
148.91M
-38.33%
166.11M
-36.22%
191.88M
-32.55%
216.74M
-29.64%
237.82M
-24.88%
269.38M
-21.74%
300.84M
-19.55%
321.33M
-19.10%
338.02M
-17.76%
358.58M
-14.96%
384.38M
-12.33%
399.43M
现金流量表
经营净额
-156.96%
-9.97M
46.95%
-7.16M
30.37%
-11.70M
37.61%
-6.49M
218.48%
17.51M
52.84%
-13.49M
32.76%
-16.80M
51.86%
-10.40M
54.01%
-14.78M
-107.51%
-28.60M
29.89%
-24.99M
-39.06%
-21.60M
-8.53%
-32.13M
47.74%
-13.78M
-168.56%
-35.64M
26.10%
-15.53M
-0.33%
-29.60M
-476.00%
-26.38M
10.87%
-13.27M
-35.96%
-21.02M
投资净额
152.88%
14.01M
373.33%
11.94M
-168.64%
-47.30M
-87.96%
2.30M
-317.38%
-26.48M
-107.45%
-4.37M
625.30%
68.90M
61.14%
19.07M
95.65%
-6.34M
25.36%
58.62M
-139.07%
-13.12M
-58.07%
11.84M
-998.57%
-145.75M
233.40%
46.77M
-26.22%
33.57M
-61.16%
28.23M
137.11%
16.22M
-237.70%
-35.05M
360.83%
45.50M
2802.68%
72.68M
融资净额
13.73%
-5.54M
-5.92%
-7.29M
1386.32%
64.14M
-15.33%
-8.32M
3.35%
-6.42M
-7.37%
-6.89M
32.16%
-4.99M
-31269.57%
-7.21M
-103.33%
-6.65M
-216.43%
-6.41M
-2541.86%
-7.35M
-100.78%
-23.00K
4751.33%
199.88M
-160.49%
-2.03M
-96.88%
301.00K
210.71%
2.93M
500.58%
4.12M
190.89%
3.35M
3121.40%
9.63M
304.72%
943.00K
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Enanta Pharmaceuticals Inc的总收入是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,总收入达到了65.32M(同比变化67.64M)。
Enanta Pharmaceuticals Inc的流动资产是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,流动资产为204.34M(同比变化-31.85)。
Enanta Pharmaceuticals Inc的总资产是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的总资产为280.73M(同比变化-25.47)。
Enanta Pharmaceuticals Inc的总负债是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的总负债为216.01M(同比变化-12.84)。
Enanta Pharmaceuticals Inc的总权益是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的总权益为64.72M(同比变化-49.76)。
Enanta Pharmaceuticals Inc的净营业收入是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的净营业收入为-85.35M(同比变化29.86)。
Enanta Pharmaceuticals Inc的净投资是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的净投资为40.35M(同比变化-30.72)。
Enanta Pharmaceuticals Inc的净融资是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的净融资为-26.62M(同比变化3.65)。
Enanta Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-3.84(同比变化30.03)。
Enanta Pharmaceuticals Inc的净利润是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,净利润为-81.89M(同比变化29.43)。
Enanta Pharmaceuticals Inc的净利润率是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,净利润率为-125.36(同比变化26.94)。
Enanta Pharmaceuticals Inc的债务与资产比率是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,债务与资产比率为50.99(同比变化14127.10)。
Enanta Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-84.63(同比变化-26.00)。
Enanta Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-24.91(同比变化9.95)。
Enanta Pharmaceuticals Inc的营业利润是多少?
根据Enanta Pharmaceuticals Inc的FY2025财报,营业利润为-85.35M(同比变化29.86)。